Rainmed Medical Ltd., a company listed on the main board of the Hong Kong Stock Exchange, has announced a subscription of new shares under a general mandate. The company has entered into a subscription agreement with Apsara Technology Limited, an independent third party, for the issuance of 233,559,800 new ordinary shares at a subscription price of HK$0.163 per share. This transaction is subject to the fulfillment of certain conditions outlined in the agreement. Shareholders and potential subscribers are advised to exercise caution when dealing with the company's shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.